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Aim.Todevelopandvalidateaquestionnairefordetectingatopicdermatitisininfantsandsmallchildrenfromtheageof2months.
Methods. Parents to 60 children answered a written questionnaire prior to a physical examination and individual semistructured
interview. Qualitative and quantitative analyses of validity, sensitivity, speciﬁcity, and predictive values of the questionnaire were
performed. Results. A total of 27 girls and 33 boys, aged 2 to 71 months, 35 with and 25 without physician-diagnosed eczema,
participated. Validation of the questionnaire by comparisons with physicians’ diagnoses showed a sensitivity of 0.91 (95% CI
0.77–0.98) and a speciﬁcity of 1 (95% CI 0.86–1). Conclusions. Three questions in a parental questionnaire were suﬃcient for
diagnosing eczema in infants and small children.
1.Introduction
Atopic dermatitis aﬀects 15 to 20% of preschool children in
western countries [1–4]. The lifetime prevalence of eczema
in children aged 1–4 years in V¨ armland county, Sweden,
was assessed in 2000 in the cohort study Dampness in
Building and Health to be 22% [5]. The burden of disease
has been assessed to be at least comparable to other chronic
illnesses, such as diabetes or neurological disorders [6–
8]. For population-based, epidemiological investigations,
parental written questionnaires detecting eczema during
childhood are advantageous. However, current question-
naires have been developed for older children and adults [9].
Given that in small children atopic dermatitis is the most
common inﬂammatory disease, the deﬁciency of validated
questionnaires diagnosing eczema in very young children
is noteworthy [10]. A questionnaire should be suitable to
the general population and therefore evaluated in such a
setting. Furthermore, it should be applicable to eczema with
diﬀerent severity categories. A new questionnaire detecting
atopic dermatitis in young children could probably be based
on previous tools for older children.
For the current study, a questionnaire was based on the
existing ISAAC (International Study of Asthma and Allergies
in Childhood) questions for school children [9]. The aim of
the current study was to estimate the diagnostic precision of
the children’s eczema questionnaire compared to physicians’
clinical diagnoses as the gold standard in preschool children
from the age of two months. Further, we evaluated whether
the parents considered the questions to be understandable
and suitable for diagnosing eczema in this age group.
2. Methods
2.1. Study Design and Procedures. Ac a s ec o n t r o ld e s i g n
similar to that used by Williams et al. in his validation study
on atopic dermatitis was chosen [11]. As seen in Figure 1,
35 children with eczema and 24 without eczema according
to medical records and aged two months to six years were
recruited consecutively from a preventive care register in2 Journal of Allergy
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Figure 1: Study procedures.
Arvika, V¨ armland County, Sweden. These 60 children’s par-
ents answered a questionnaire on eczema (the questionnaire
to be evaluated). Then, these 60 children were examined
by a physician. Physician diagnosis, based on the presence
of at least three major and three minor criteria of Haniﬁn
and Rajka’s diagnostic criteria [12, 13], was used as the
gold standard to validate the questionnaire. The physician
was blinded to the answers of the questionnaire. In clinical
eczema cases, severity was measured with the SCORing
Atopic Dermatitis (SCORAD) index [14]. Furthermore, all
parents answered a background questionnaire.
The qualitative part of the investigation was carried out
by means of a semistructured, one-to-one interview with
the parents. The interview started with a general discus-
sion regarding the understanding of the eczema questions
and relevance of named issues on infants’ and preschool
children’s eczema. Each interview was conducted by the
same physician, the ﬁrst author of this paper, to ensure
consistency. The interview was transcribed and approved by
the responders.
The regional ethical committee in Uppsala approved the
protocol for the study, Dnr-C2007/41. Written consent was
obtained 2 weeks prior to study start.
2.2. Study Population. Inclusion criteria for index cases
were eczema, treated either with emollients or topical
glucocorticoids. Inclusion criteria for controls were an age
of two month to six years and no eczema. Exclusion criteria
were eczema treated with systemic treatment, other chronic
diseases such as diabetes, acute infections, or if parents did
not understand or speak Swedish ﬂuently. A power analysis
showed we would need 60 children to assess sensitivity and
speciﬁcity with a power of 0.8 and alpha 0.05 [15]. A total
of 62 children were invited to participate, but there were two
denials. Data on 60 children could be analysed.
2.3. How the Parental Questionnaire was Constructed. Atopic
dermatitis was deﬁned by Haniﬁn and Rajka as pruritic,
chronically relapsing dermatitis, with typical features and
distribution [13]. Our questionnaire was constructed to
discriminate whether these essential signs of eczema existed
in each child or not. The questions we used for this were
derived from the ISAAC protocol, which was developed for
school children. We used the main outcome measure of the
ISAAC protocol, “Has your child ever had an itchy rash
which was coming and going for at least 6 months?”, and
the question, which is an additional question in the ISAAC
protocol “Has this itchy rash at any time aﬀected any of the
following places: the folds of the elbows, behind the knees,
in front of the ankles, under the buttocks, or around the
neck, ears or eyes?”. We adopted the questions to the age
group in our study. The main adoption was that we divided
the main outcome measure of the ISAAC protocol into two
parts, thus we asked for chronic relapsing dermatitis and itch
in two separate questions. Further, we extended the list of
involved sites, since more sites can be involved in younger
children. Involved sites were in agreement with Halkjaer’s
description of eczema distribution in young children [16],
and face validity was conﬁrmed by comparing our criteria
with the UK diagnostic criteria for atopic eczema [11].
The three key questions are as follows.
(i) Does your child have or has your child had a red
rash/eczema which can come and go?
(ii) If Yes, has this caused itching or scratching?
(iii) Has this red rash/eczema aﬀected any of the following
areas (during the last week): Around the eyes,
ears, scalp, cheeks, forehead, neck, trunk, folds of
the elbows/behind the knees, wrist or ankle, outer
arms/legs?
The children had to answer “yes” in each of the three
questions to be classiﬁed as a questionnaire diagnosed
eczema.
3.Analysis
3.1. Quantitative Analyses. A questionnaire-diagnosed
eczema was compared to a physician’s diagnosis which was
the gold standard. Sensitivity and speciﬁcity as well as the
positive predictive value (PPV) and negative predictive value
(NPV) of the sample population and stratiﬁed age groups
were assessed.
PPV was calculated as (prevalence × sensitivity)/
(prevalence × sensitivity + (1 − prevalence) × (1 − speci-
ﬁcity)) [17]. NPV was calculated as (1 − prevalence)/((1 −
prevalence)+prevalence ×(1 −sensitivity)/speciﬁcity)[18].
Therewasnomissingdata.Statisticalanalysiswasperformed
with Stata tm 10.1 Statistics Data Analysis.
3.2. Qualitative Analysis. Data was analysed according to
content [19]. The most commonly mentioned and coded
topics formed the basis of further deﬁning themes and
patterns. Interpretations were compared to the original data
for internal corroboration or disconﬁrmation. Findings were
summarized regarding the understanding of the eczema
concept and relevance of the diagnostic questions.Journal of Allergy 3
Table 1: Baseline characteristics of children with and without
eczema due to speciﬁc criteria.
Patients’ diagnose status
Eczemaa Noneczema Total
Number, n (%) 35 (58.3) 25 (41.7) 60 (100)
Age (month)
Mean (SD) 25.96 (±19.1) 25.68 (±18.3) 25.84 (±18.6)
Median (range) 18.0 (4–66) 19.0 (2–60) 19.0 (2–66)
Sex, n (%)
Female 19 (54.3) 8 (32.0) 27 (45.0)
Male 16 (45.7) 17 (68.0) 33 (55.0)
Heredity, n (%)
Yes 27 (77.1) 15 (60.0) 42 (70.0)
No 8 (22.9) 10 (40.0) 18 (30.0)
Dry skin, n (%)
Yes 27 (81.8)∗ 6 (18.2)∗ 35 (58.3)
No 8 (29.63)∗ 19 (70.4)∗ 25 (41.7)
SCORAD
Scoreb, n (%)
Severe 6 (17.1)
Moderate 15 (42.9)
Mild 14 (40.0)
aPhysician diagnose, based on Haniﬁn and Rajka’s criteria.
bEczema severity assessed with SCORing Atopic Dermatitis.
∗P (Pearson chi2(1)) < 0.05.
4. Results
4.1. Patient Characteristics. Eczema occurred in 35 children,
who reported dry skin twice as much as children without
eczema (Table 1). Both children with and without atopic
dermatitis manifested other skin disorders at the same rate
as miliaria, haemangioma, keratosis pilaris, and melanocytic
naevi. In the eczema group, eleven (33%) children awoke
several times per week, and 2 (6%) awoke occasionally
because of skin symptoms according to parental reports. The
treatmentofthechildrenwitheczemaconsistedofemollients
and topical glucocorticoids. The latter had been used in only
twocases during the lastweek. No otheractive treatmentwas
reported. Further characteristics of the children are shown in
Table 1.
4.2. Validation of the Used Questionnaire. A combination of
aﬃrmative answers to all three key questions, rash, itch, and
location, predicted clinical eczema with good sensitivity 0.91
(95% CI 0.77 to 0.98) and speciﬁcity 1 (95% CI 0.86 to 1).
Predictive values were PPV = 1a n dN P V= 0.976.
Diagnostic accuracy by age groups was similar (Table 2).
4.3. Results of the Qualitative Study. Most parents judged the
questions to be understandable and suitable—“even if I do
not deal much with asthma and allergy.” According to the
parents, the questionnaire covered all the important facts
regarding the eczema diagnosis. However, disease terms were
regarded to be diﬃcult; “eczema is too strong an expression
to answer yes to” whereas questions concerning symptoms
Table 2: Validation of the used questionnaire by comparison of
parental reported eczema with physician diagnose of the children
by age group.
Patients’ age
(month)
Psychometric measures
Sensitivity
(95% CI)
Speciﬁcity
(95% CI)
Positive
predictive
value
Negative
predictive
value
0t o2 3 0.91
(0.70–0.99)
1
(0.81–1)b 10 . 9 7
≥24 0.93
(0.66–1.00)
1
(0.76–1)b 10 . 9 8
0t o6 6( t o t a l ) 0.914
(0.77–0.98)
1
(0.89–1)b 10 . 9 8
bSingle sided 95% CI.
were thought to be easily answered—“easy, one can already
see itching at the age of 6 months.”
Of 35 parents to children with eczema, 21 expressed
feelings of stress and worry about their child’s health state
and felt responsible for it. Four parents reported not wishing
their children to be diagnosed with eczema at all because of
fear of cortisone treatment. Itching and awakening due to
itching were regarded as the most burdensome symptoms.
5. Discussion
With three key questions, atopic dermatitis in preschool
children can be identiﬁed via a parental questionnaire.
The high sensitivity and speciﬁcity indicate that this ques-
tionnaire is a valuable diagnostic tool. Validated eczema
questionnaires have been available for school children only.
But the incidence of eczema is highest in preschool children.
Our questionnaire provides a feasible diagnostic tool with
high diagnostic precision, which can add to the ﬁeld of
epidemiological research in early childhood eczema.
The semistructured interview conﬁrmed high face and
content validity, which might be one reason for the high
proportion of children with detectable eczema. The PPV
of the questionnaire is the proportion of children with a
positiveresultwhoactuallyhadphysician-diagnosedeczema.
Predictive values are, however, related to the prevalence of
eczema in the population, which could not be assessed with
this study design. The high prevalence of eczema, 22%, in
the population was derived from data from the same county
[5]. The results suggested that the risk of diagnosing eczema
in healthy infants and small children was low. Sensitivity
measures the proportion of actual positives, which are
correctly identiﬁed as such. Even the measured sensitivity
was high, indicating that not many eczema diagnoses were
missed. The questionnaire did not suggest healthy children
to be diseased, as shown by the high speciﬁcity.
Itisimportanttoestimatetheseverityofeczema,bothfor
thedescriptionofthestudypopulationandforanassessment
of generalizability. A score combining an assessment of
disease extent with clinical features, duration plus intensity
(SCORAD) was used [14]. Based on this assessment, partic-
ipating children showed mild-to-severe eczema that allows
applying the questionnaire in all severity groups.4 Journal of Allergy
The strength of the study is the population-based setting,
as the questionnaire is intended to be used in a similar
setting. Because all children were registered in a preventive
care register and almost all invited children participated,
it is unlikely that selection bias occurred, even though the
sample was not randomly selected. Assessing the diagnostic
accuracy of the diagnostic test on a sample of the general
preschool child population allows generalizing results. The
narrow conﬁdence intervals suggest that the sample size was
adequate and that estimates of the population value are
within a reasonable range. Compared to a standardized skin
examination protocol, the ISAAC questionnaire performed
well in predicting eczema prevalence at the population level.
However,onanindividuallevel,ahighproportionofﬂexural
eczemawasnot conﬁrmedbyskin examination [20].Astudy
from Brazil tested the ISAAC questionnaire against a gold
standard. Even here a high proportion of the ISAAC cases
were false and many physician-diagnosed cases were missed
[21]. In contrast, our study showed good performance on an
individual level. This does not mean that our questionnaire
is to be preferred but that the questions which we adopted
to our cultural environment might be useful in Sweden as
shown by the validation against a gold standard. In diﬀerent
linguistic and cultural contexts, an adoption of the questions
and new validation should be considered [22]. It is for
example possible that the questionnaire performs diﬀerently
in populations with less access to health care.
6. Conclusions
This study makes a contribution in solving diagnostic prob-
lems wherethere has been a lack of diagnostic questionnaires
for small children. The questionnaire can be used in a
population-based setting and across diﬀerent severity groups
of eczema. It is, however, important to take cultural aspects
into account.
Abbreviations
SCORAD: SCORing Atopic Dermatitis
PPV: Positive predictive value
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